)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Delcath Systems
Delcath Systems (DCTH) investor relations material
Delcath Systems Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary26 Feb, 2026
Executive summary
Achieved record annual revenue of $85.2 million in 2025, up over 40% year-over-year, with $20.7 million in Q4 alone.
HEPZATO KIT drove $78.8 million in annual revenue, with CHEMOSAT contributing $6.4 million.
Ended 2025 with 28 active treatment centers and 140% growth in HEPZATO procedure volume compared to 2024, targeting 40 centers by end of 2026.
CHOPIN trial data demonstrated significant clinical benefit for PHP when sequenced with checkpoint inhibitors, with publication imminent.
Commercial strategy focuses on expanding site capacity, changing prescribing patterns, and building referral networks.
Financial highlights
Q4 2025 revenue: $19 million from HEPZATO and $1.7 million from CHEMOSAT; full year: $78.8 million HEPZATO, $6.4 million CHEMOSAT.
Gross margins: 85% in Q4 and 86% for 2025, up from 83% in 2024.
Q4 2025 net loss: $1.9 million (improved from $3.4 million loss in Q4 2024); full year 2025 net income: $2.7 million (vs. $26.4 million loss in 2024).
Adjusted EBITDA for 2025: $25.1 million, up from a $2.5 million loss in 2024.
Ended 2025 with $91 million in cash and investments; $22.5 million operating cash flow for the year.
Outlook and guidance
2026 revenue guidance: at least $100 million, with >20% HEPZATO KIT volume growth and >10% CHEMOSAT growth.
Gross margin guidance for 2026: 84%-87%, with potential to reach 90% in 2027 and beyond.
R&D expenses expected to increase by nearly 90% in 2026; SG&A to rise by nearly 50%.
Anticipates accelerated adoption and utilization driven by new site activations and positive clinical data.
Average selling price for HEPZATO projected at $175,000 per kit, reflecting a 10% discount due to 340B pricing.
What drives the 2026 HEPZATO volume growth forecast
HEPZATO mCRC/mBC trial: market potential
How CHOPIN data changes HEPZATO commercial strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Delcath Systems earnings date
Q1 20267 May, 2026
Delcath Systems
Next Delcath Systems earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Delcath Systems Inc. is a medical technology company focused on the development and commercialization of innovative therapies for cancers with limited treatment options. The company specializes in targeted drug delivery systems, designed to isolate and deliver high doses of chemotherapy to specific organs or regions while minimizing systemic exposure. The company is headquartered in Wilmington, Delaware, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage